13F Pro quality score
Rank #916 of 2,925TOP 50%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from GE HealthCare Technologies Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $20.6B | $2.1B | 13.4% |
| FY 2024 | 10-K | $19.7B | $2.0B | 13.3% |
| FY 2023 | 10-K | $19.6B | $1.6B | 12.4% |
| FY 2022 | 10-K | $18.3B | $1.9B | 13.8% |
| FY 2021 | 10-K | $17.6B | $2.2B | 15.9% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
6 transactions in GEHC reported by 4 members of Congress under the STOCK Act, most recent trade Mar 25, 2026. Reported transactions, not recommendations.
GE HealthCare Technologies Inc. (GEHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GEHC at 59.6/100 on a composite quality score built from its SEC filings, placing it at rank #916 of 2,925 stocks — the top half of the AI-ranked universe. GEHC scores in the top quartile across revenue scale (92.7). Based on the latest XBRL financial filings (Q2 2026), GE HealthCare Technologies Inc. reports quarterly revenue of $5.3B, net income of $561.0M, an operating margin of 14.0%. Top institutional holders of GEHC by reported 13-F value include DODGE & COX, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GEHC trades on the Nasdaq exchange and files with the SEC under CIK 1932393. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GEHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GE HealthCare Technologies Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1932393 →